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from inhibitory control via spinal interneurones, thus facilitating 
the transmission of nociceptive information (Ahmadi et al., 2002; 
Reinold et al., 2005). One such mechanism of spinal disinhibition 
occurs through the postsynaptic activation of G-protein-coupled 
EP2 receptors, and subsequent protein kinase A induced inhibition 
of α3 subunit containing glycine receptors, present in the superﬁ  cial 
laminae of the spinal cord (Harvey et al., 2004).
GlyR α3 subunit knockout mice (Glra3−/−) allow us to probe 
the function of this ligand-gated ion channel in the absence of any 
 subtype-selective ligands. Previously, a role for GlyR α3 in inﬂ  amma-
tory pain has been demonstrated in the CFA and zymosan A models 
of peripheral inﬂ  ammation (Harvey et al., 2004). By contrast, GlyR 
α3 appears to have little or no role in neuropathic pain and the 
formalin test (Racz et al., 2005; Hösl et al., 2006). In this study, we 
have investigated the nociceptive phenotypes of GlyR α3 knock-
out mice in acute models of inﬂ  ammation and clinically relevant 
models of persistent inﬂ  ammatory, neuropathic and visceral pain. 
Moreover, we investigated the role of GlyR α3 in response to multi-
modal suprathreshold stimuli-evoking responses, which equate to 
higher pain scores experienced by human pain patients.
MATERIALS AND METHODS
ANIMALS
Glra3−/− mice on a C57Bl/6 background were produced as described 
(Harvey et al., 2004). Glra3−/− mice and their wild-type littermates 
were group housed on a standard 12-h light/dark cycle with food 
and water available ad libitum except during behavioural testing. 
INTRODUCTION
Despite recent developments in the understanding of pain 
 mechanisms and analgesia, the relief of pain, particularly that which 
lasts over long periods, remains a principal concern to healthcare 
professionals. Chronic pain can be broadly categorised into three 
types: inﬂ  ammatory, neuropathic and dysfunctional. Inﬂ  ammatory 
pain, arising from tissue damage caused by trauma or infection, is 
 associated with conditions such as arthritis. Neuropathic pain, arising 
from trauma to, or pathological changes in, the peripheral or central 
nervous systems can occur as a consequence of stroke, ischaemia, 
diabetes or nerve infection (e.g. HIV, shingles, etc.). The third type 
of pain is underpinned by neural dysfunction and is thought to be 
associated with conditions such as irritable bowel syndrome (IBS), 
ﬁ  bromyalgia and migraine which manifest as non-localised diffuse 
pain unaccompanied by either inﬂ  ammation or nerve damage.
Tissue damage precipitates the release of multifarious endog-
enous pro-inﬂ  ammatory mediators at sites in both the periphery 
and the CNS (mainly at the level of the spinal cord). Peripheral 
release of these mediators, namely prostaglandin E2 (PGE2), leads to 
the sensitization of primary afferents, thereby lowering thresholds 
for neuronal activation, and increasing nociceptor responsivity. This 
increased peripheral activity contributes to spinal hypersensitivity 
(central sensitisation) resulting in increased responsivity to noxious 
stimulation termed hyperalgesia, and allodynia where normally non-
noxious stimuli such as cooling, gentle touch, movement and pres-
sure are now perceived as being painful. Central  prostanoid release 
can induce spinal disinhibition, relieving dorsal horn neurones 
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Experiments were performed on animals of at least 8 weeks of age. 
For all the experiments detailed in this study, the observer was 
blinded with respect to mouse genotype. All experiments were car-
ried out in accordance with the UK Home Ofﬁ  ce Animals Scientiﬁ  c 
procedures Act (1986).
INDUCTION AND BEHAVIOURAL ANALYSIS OF PAIN STATES
Glra3−/− and wild-type littermates received either unilateral intra-
plantar injections of 1 mg/ml complete Freund’s adjuvant (CFA, 
20 µl), 2% (w/v) carrageenan (20 µl) or 50 µg/ml capsaicin (5 µl). 
Models of rheumatoid arthritis and osteoarthritis were induced 
by unilateral intra-articular injections of 3% (w/v) kaolin/carra-
geenan (K/C; 15 µl), or 5 mg/ml monosodium iodoacetate (MIA, 
10 µl;  Harvey and Dickenson, 2009), respectively. Neuropathic 
(partial sciatic nerve ligation, PSNL) mice were prepared by uni-
lateral tight ligation of 1/3 to 1/2 of the sciatic nerve using 7-0 silk 
under isoﬂ  uorane/O2 anaesthesia (Malmberg and Basbaum, 1998). 
Behavioural thermal hypersensitivity (thermal hyperalgesia) was 
assessed using the Hargreaves’ test and the hot plate, and mechani-
cal hypersensitivity (mechanical allodynia) was assessed using von 
Frey ﬁ  laments as described (Harvey and Dickenson, 2009). Two 
baseline measurements were recorded prior to the induction of the 
pain models. Although both contralateral and ipsilateral limbs were 
tested, only ipsilateral data are shown for clarity since contralateral 
data were not signiﬁ  cantly different from baseline following the 
induction of any pain model (p > 0.05). Capsaicin-induced acute 
spontaneous pain behaviours, measured as either biting, ﬂ  inching, 
or licking, were measured for 3 min.
SPINAL CORD ELECTROPHYSIOLOGY
Following a laminectomy (L3–L6) in vivo electrophysiology was 
performed in urethane anesthetised (240  mg/kg) Glra3−/− and 
wild-type mice using parylene coated tungsten electrodes (A-M 
Systems, USA), as previously described (Harvey and Dickenson, 
2009). Evoked neuronal responses were recorded from single wide 
dynamic range dorsal horn neurones receiving inputs from the 
hindpaw. Transcutaneous electrical stimuli consisted of a train of 
16 electrical stimuli (2 ms wide pulses, 0.5 Hz, 3 × C ﬁ  bre thresh-
old), were delivered by means of pins inserted in to the hindpaw. 
Post stimulus time histograms were constructed and ﬁ  bre responses 
were separated according to the following latencies: A (0–50 ms), 
C (50–250  ms) and post discharge (250–800  ms). Input (i.e. 
non-potentiated response) is measured as the number of action 
potentials in response to the initial stimulus × 16 (total number of 
stimuli). Wind up values, a measure of the temporal summation 
of neuronal activity in response to a train of stimuli, was calcu-
lated as the total number of action potentials evoked at the end 
of 16 stimuli minus the input. A wide range of natural stimuli 
including brush (dynamic mechanical) acetone (innocuous cold), 
and graded punctate mechanical and thermal stimuli applied using 
von Frey ﬁ  laments and a water jet, respectively, were applied to the 
hindpaw for a period of 10 s. Data were captured and analysed using 
a CED 1401 interface coupled to a Pentium computer running Spike 
2 software (Cambridge Electronic Design).
ACUTE VISCERAL NOCICEPTION
Visceral nociception was assessed using a method adapted from 
Kamp et al. (2003). Under isoﬂ  uorane anaesthesia (2.5%, delivered 
in O2), an electromyographic (EMG) electrode (insulated copper 
wire, exposed at the ends and 1 cm centrally) was sewn into the 
external oblique muscle. A latex balloon (20 mm) attached to a 
pressure transducer via polyethylene tubing, with the distal 15 mm 
perforated using a 27-gauge needle to facilitate balloon inﬂ  ation, 
was inserted intra-anally (25 mm), and secured by surgical tape 
to the base of the tail. The anaesthesia was gradually reduced to 
∼1% isoﬂ  uorane, and allowed to equilibrate for at least 30 min, 
such that the animals did not display spontaneous movement but 
responded to cutaneous hindpaw stimulation. EMG responses were 
ﬁ  ltered, ampliﬁ  ed and recorded in 10 s prior to and during color-
ectal distensions (10 s) of 10–60 mmHg applied at 4 min intervals. 
Two consecutive sets of CRD were recorded and averaged. Data 
are presented relative to the mean wild type maximum response 
(60 mmHg).
RESULTS
ACUTE NOCICEPTION
Pain thresholds to punctate mechanical stimuli were measured in 
Glra3−/− mice and wild-type littermates using calibrated von Frey 
hairs, according to the up–down method (Chaplan et al., 1994). Paw 
withdrawal thresholds to mechanical stimuli were not signiﬁ  cantly 
different between groups (p > 0.05; Figure 1A). Similarly, thermal 
thresholds assessed using the Hargreaves’ test were  indistinguishable 
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FIGURE 1 | Glra3−/− mice show no differences in their acute pain 
behaviours. (A) Punctate mechanical stimulation using calibrated von Frey 
(Glra3−/−, n = 16; wild type, n = 10). Thermal stimulation using either (B) the 
Hargreaves’ apparatus (Glra3−/−, n = 30; wild type, n = 19) or (C) the hot plate at 
50°C or 55°C (Glra3−/−, n = 12; wild type, n = 12). Data are presented as 
mean ± SEM.Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 14  |  3
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between groups (p > 0.05; Figure 1B). Thermal hypersensitivities 
were similar across genotypes when measured using the hot plate 
at either 50°C or 55°C (p > 0.05; Figure 1C). This absence of an 
acute phenotype in Glra3−/− mice agrees with previous ﬁ  ndings 
(Harvey et al., 2004).
Spinal cord electrophysiology was performed to assess the poten-
tial role of GlyR α3 in acute nociception in response to multi-
modal stimuli. Where behaviour lends information concerning 
threshold intensities, electrophysiology can be used to inform us 
about responses to suprathreshold stimuli. Single unit dorsal horn 
neuronal recordings were performed in Glra3−/− (n = 27) and wild-
type littermates (n = 22). The mean depths from the surface of the 
spinal cord were not signiﬁ  cantly different between groups and 
correspond to the deep laminae of the spinal cord 550 ± 30 µm and 
459 ± 38 µm (p > 0.05), respectively ensuring that the population 
of neurons was similar between the two groups, and hence direct 
comparisons were possible. Responses to electrical, brush, acetone, 
noxious cold and pinch (Table 1); as well as graded mechanical 
and thermal stimuli (Figures 2A,B) were indistinguishable between 
genotypes (p > 0.05).
INFLAMMATORY PAIN BEHAVIOUR
Consistent with previously reported ﬁ  ndings (Harvey et al., 2004) 
Glra3−/− mice displayed showed no difference in the induction of 
thermal pain sensitisation following CFA (20 µl) injection, but 
recovered much more quickly compared with wild-type litter-
mate controls (Figure 3A). Paw withdrawal latencies to thermal 
stimulation using the Hargreaves’ apparatus were signiﬁ  cant versus 
contralateral responses for wild-type mice days 1–6 and days 1–3 
for Glra3−/− mice (p < 0.001). Consistent with previous ﬁ  ndings, 
Glra3−/− mice (n = 7) displayed signiﬁ  cant differences in thermal 
hypersensitivity at 4, 5 and 6 days following CFA injection com-
pared with wild-type littermates (n = 5, p < 0.01).
Acute cutaneous neurogenic inﬂ  ammation induced by intra-
dermal injection of capsaicin (5 µl; 50 µg/ml) elicited spontane-
ous pain behaviour in both Glra3−/− and wild-type control mice 
(Figure 3B). No signiﬁ  cant differences were observed between the 
type of nociceptive behaviour (i.e. licking, biting and ﬂ  inching) or 
the duration of such responses (p > 0.05).
Intraplantar injection of carrageenan (20 µl; 2% w/v) elicited 
signiﬁ  cant thermal and mechanical hypersensitivities in both 
Glra3−/− and wild-type control mice at both acute (2–6 h), and 
sub-acute phases (24 h) (p < 0.05–p < 0.001; Glra3−/−, n = 5; wild 
type, n = 7; Figures 3C,D). Statistical analysis revealed no sig-
niﬁ  cant difference in Glra3−/− mice in either the magnitude or 
duration of thermal and mechanical hypersensitivities following 
carrageenan injection when compared with wild-type control lit-
termates (p > 0.05).
Clinically relevant models of inﬂ  ammation
Intra-articular injection of monosodium iodoacetate (MIA, 7 µl; 
5 mg/ml) to induce osteoarthritis (OA) evoked signiﬁ  cant behav-
ioural mechanical hypersensitivitiy in both Glra3−/− and wild-
type control mice when compared with contralateral controls 
(n = 6; p < 0.001; Figure 4A). Thermal hypersensitivity was not 
explored since this has been found to be absent in this model 
(Harvey and Dickenson, 2009). Similarly, a model of rheuma-
toid arthritis (kaolin/carrageenan; 15 µl, 3% w/v) evoked sig-
niﬁ  cant thermal hypersensitivity in both Glra3−/− and wild-type 
control mice when compared with contralateral controls (n = 6; 
p < 0.05; Figure 4B). No signiﬁ  cant differences were observed 
between genotypes.
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FIGURE 2 | Glra3−/−   mice show no differences in evoked dorsal horn neuronal responses. (A) Graded mechanical stimuli (von Frey); (B) graded thermal stimuli 
(water jet). Data are presented as mean ± SEM (Glra3−/−, n = 27; wild type, n = 22).
Table 1 | Glra3−/− mice show no alteration in their neuronal responses to 
multimodal stimuli. Data are presented as mean ± SEM for deep dorsal 
horn neurones recorded in Glra3−/− (n = 27) and wild-type mice (n = 22). AP 
represents the mean number of action potentials in response to either a 
peripheral electrical or 10-s natural stimulus.
  Glra3−/− Wild  type
A-ﬁ  bre threshold (mA)  0.05 ± 0.08  0.07 ± 0.02
C-ﬁ  bre threshold (mA)  0.94 ± 0.18  0.92 ± 0.16
A-ﬁ  bre response (AP)  105 ± 10  85 ± 9
C-ﬁ  bre response (AP)  181 ± 19  143 ± 18
Post discharge (AP)  180 ± 25  155 ± 21
Input (AP)  216 ± 28  199 ± 29
Wind-up (AP)  186 ± 31  118 ± 20
Brush (AP)  67 ± 22  61 ± 14
Pinch (AP)  172 ± 29  154 ± 25
Acetone (AP)  14 ± 5  8 ± 5
1°C 60  ± 11  48 ± 20Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 14  |  4
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NEUROPATHIC PAIN BEHAVIOUR
Following the induction of peripheral nerve injury using the partial 
sciatic nerve ligation model, both Glra3−/− and wild-type littermates 
developed robust and persistent mechanical and thermal hyper-
sensitivities from the onset of testing (Figures 5A,B). Signiﬁ  cant 
mechanical hypersensitivity was observed in Glra3−/− mice at days 
3, 5, 7 and 14 (p < 0.01–p < 0.001) and wild-type mice at days 
3–14 (p < 0.05–p < 0.01) following surgery compared with con-
tralateral controls (n = 6). Signiﬁ  cant thermal hypersensitivity was 
observed in Glra3−/− mice and wild-type mice at all days following 
surgery (p < 0.001) compared with contralateral controls (n = 6). 
Statistical analysis revealed no signiﬁ  cant difference in Glra3−/− mice 
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FIGURE 4 | Glra3−/− mice show no differences in behavioural 
hypersensitivity in models of osteoarthritis or rheumatoid arthritis. 
(A) Signiﬁ  cant mechanical hypersensitivity was observed at all timepoints 
following unilateral intra-articular MIA (10 µl, 5 mg/ml) in both genotypes when 
compared with contralateral controls (n = 6; p < 0.001). (B) Signiﬁ  cant thermal 
hypersensitivity was observed at days 1 and 2 following unilateral intra-articular 
K/C injection (15 µl, 3% w/v) in both genotypes when compared with 
contralateral controls (n = 6; p < 0.05). No differences were observed between 
genotypes. Data are presented as mean ± SEM and analysed using two-way 
repeated measures ANOVA, Bonferroni post hoc analysis.
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FIGURE 3 | Glra3−/− mice display attenuated CFA behaviour, but show no 
differences in other inﬂ  ammatory models. (A) Paw withdrawal latencies 
following unilateral intraplantar CFA (20 µl) were signiﬁ  cant versus contralateral 
responses for wild-type mice days 1–6 and days 1–3 for Glra3−/− mice (p < 0.001). 
Paw withdrawal latencies of Glra3−/− mice were signiﬁ  cantly different from wild-
type mice at days 4 (p < 0.01, **), 5 and 6 (p < 0.001, ***) (Glra3−/−, n = 7; wild 
type, n = 5). (B) Total nociceptive behaviour following unilateral intraplantar 
capsaicin (5 µl, 50 µg/ml) was not signiﬁ  cantly different between genotypes 
(Glra3−/−, n = 12; wild type, n = 12). (C) Signiﬁ  cant mechanical hypersensitivity and 
(D) thermal hypersensitivity was observed at all timepoints following unilateral 
intraplantar carrageenan (20 µl, 2% w/v) when compared with contralateral 
controls (p < 0.05 –p < 0.001) but indistinguishable between genotypes (Glra3−/−, 
n = 5; wild type, n = 7). Data are presented as mean ± SEM and analysed using 
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in either the magnitude or duration of thermal and mechanical 
  hypersensitivities following the induction of nerve injury when 
compared with wild-type control littermates (p > 0.05).
VISCERAL PAIN
The visceromotor response (VMR), evoked by the distension 
of the colon by a balloon inserted intra-colonically, provides 
a quantiﬁ  able measure of visceral pain (visceral hyperalgesia). 
In rodents, pressures which elicit pain in humans evoke graded 
abdominal muscle contractions (measured as the VMR), tachy-
cardia and the activation of primary afferent visceral nerves (e.g. 
pelvic nerve) and subsequent activation of second order pro-
jection neurones (Kamp et al., 2003). The response measured 
at 0 mmHg (with the balloon deﬂ  ated) was considered as the 
baseline response; 30 mmHg was considered mildly noxious and 
60 mmHg as signiﬁ  cantly noxious. Both wild-type and Glra3−/− 
mice displayed coded responses to the graded stimuli (Figure 6), 
however, the responses were not signiﬁ  cantly different between 
the groups (p > 0.05).
DISCUSSION
This study conﬁ  rms, consistent with previous ﬁ  ndings, that GlyR 
α3 has a signiﬁ  cant role in certain inﬂ  ammatory pain states. In this 
study, we have used knockout mice to investigate the role of GlyR 
α3 in a variety of acute, persistent and clinically relevant behav-
ioural pain models as well as neuropathic and visceral pain models. 
Moreover, in vivo electrophysiology has been used to investigate 
the potential role of these channels in response to suprathreshold 
stimuli, which equate to intensities that produce high pain scores 
such as those seen in the clinic.
ACUTE PAIN THRESHOLDS
Consistent with previous ﬁ  ndings, acute behavioural thermal and 
mechanical thresholds in Glra3−/− mice were unaltered (Harvey 
et al., 2004). These behavioural ﬁ  ndings are re-enforced by the 
electrophysiological characterisation of Glra3−/− mice to an array 
of different modalities ranging from threshold to suprathreshold 
intensities, suggesting that GlyR α3 is not implicated in acute 
  nociception. These characteristics are advantageous when inves-
tigating potential therapeutic targets since ideal analgesic targets 
should be pain-state speciﬁ  c, leaving normal nociceptive processing 
and thus normal sensation unaltered.
INFLAMMATORY PAIN MODELS
Although the role of GlyR α3 in inﬂ  ammatory pain has been pre-
viously investigated in selected models, this study expands on the 
current work by investigating its potential role in other inﬂ  amma-
tory pain states including capsaicin and carrageenan inﬂ  ammation 
and clinically relevant models such as the kaolin/carrageenan (K/C) 
model of rheumatoid arthritis and the monosodium iodoacetate 
model of osteoarthritis. CFA-induced behavioural hypersensitiv-
ity was reconﬁ  rmed in this study, where Glra3−/− mice displayed 
an accelerated rate of recovery, in line with previous ﬁ  ndings 
(Harvey et al., 2004). Since GlyR α3 displayed this inﬂ  ammatory 
phenotype, its potential role in other models of inﬂ  ammation 
was investigated.
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FIGURE 5 | Glra3−/− mice show no differences in behavioural 
hypersensitivitiy following experimentally induced peripheral neuropathy. 
(A) Signiﬁ  cant mechanical hypersensitivity was observed in Glra3−/− mice at days 
3, 5, 7 and 14 (p < 0.01–p < 0.001) and wild-type mice at days 3–14 (p < 0.05–
p < 0.01) following surgery compared with contralateral controls (n = 6). 
(B) Signiﬁ  cant thermal hypersensitivity was observed in Glra3−/− mice and wild-
type mice at all days following surgery (p < 0.001) compared with contralateral 
controls (n = 6). No differences were observed between genotypes. Data are 
presented as mean ± SEM and analysed using two-way repeated measures 
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Intraplantar capsaicin elicits immediate spontaneous pain 
behaviour in rodents through the activation of the vanilloid recep-
tor 1 (VR1/TRPV1). This evoked nocifensive behaviour is thought 
to arise from the direct activation of C-ﬁ  bres rather than as a conse-
quence of local inﬂ  ammation per se. Although capsaicin-induced C 
ﬁ  bre activation has previously been found to elicit prostaglandin E2 
release in spinal cord slices (Malmberg and Yaksh, 1994), the exact 
spinal mechanisms have not been fully established. In this study, 
no behavioural phenotype was observed following intraplantar 
capsaicin injection in Glra3−/− mice.
Intraplantar injection of carrageenan evokes both mechanical 
and thermal hypersensitivity in rodents. These behaviours can 
be subdivided into an acute phase (2–6 h) and sub-acute phase 
(24 h) (Kolhekar et al., 1997). Prostaglandin synthesis occurs both 
at peripheral and spinal sites since both systemic and intrathecal 
cyclo-oxygenase (COX) inhibition attenuates nocifensive behav-
iour. However, intrathecal COX inhibitors were only effective when 
given prior to carrageenan injection (Dirig et al., 1998). A later 
study found that spinal CSF levels of PGE2 peaked in the acute 
phase but remained signiﬁ  cantly elevated up to 24 h (Guay et al., 
2004). Taken together, this suggests that there is potentially only a 
limited time frame where spinal PGE2 is contributing to the pain 
behaviours, whereas peripheral or supraspinal sites are involved 
in both the induction and maintenance of carrageenan-evoked pain 
behaviours. In this study, no phenotype was observed in either the 
acute or sub-acute phase of carrageenan behavioural hypersensitiv-
ity in Glra3−/− mice. Therefore, although spinal prostaglandins are 
involved in the induction, and to a lesser extent the maintenance 
of this model, the EP2 receptor – GlyR α3 signalling pathway is 
unlikely to represent the downstream substrate.
ARTHRITIC PAIN MODELS
Arthritic pain, as a result of either rheumatoid arthritis or osteoar-
thritis, represents a major chronic healthcare problem escalating 
with our aging and obese population (Neugebauer et al., 2007). 
Although different models exist for their study, the chemical mod-
els of MIA, for osteoarthritis, and K/C for rheumatoid arthritis, 
are popular among pain researchers. In this study, mice displayed 
signiﬁ  cant behavioural hypersensitivity in the paw of the affected 
limb in both arthritic models, consistent with other literature 
(Yang et al., 1996; Harvey and Dickenson, 2009). Similar to other 
peripheral inﬂ  ammatory models, spinal prostanoids are thought 
to contribute largely to the observed pain behaviours. Infrapatellar 
K/C injection leads to a robust and persistent (up to 72 h) increase 
in spinal PGE2 levels in rats (Dirig and Yaksh, 1999). In the MIA 
model of osteoarthritis, NSAIDs are only effective at the early stages 
of the model, suggesting a switch in the underlying mechanisms at 
later time points although these have not yet been fully established 
(Bove et al., 2003; Pomonis et al., 2005; Vonsy et al., 2008). In this 
study, it would appear that despite good evidence for central pros-
tanoid release, GlyR α3 is not implicated in the underlying pain 
pathophysiology.
NEUROPATHIC PAIN
The beneﬁ  ts of using NSAIDs to treat neuropathic pain remains 
controversial, and at best they may only be effective at very early 
stages following the nerve insult (Ma et al., 2002; Schafers et al., 
2004). In this study, analysis of the pain behaviours following 
the induction of peripheral nerve injury using the partial sciatic 
nerve injury model revealed that Glra3−/− mice developed profound 
mechanical and thermal hypersensitivities indistinguishable from 
wild-type littermates. This is in accordance with previous studies 
investigating the role of GlyR α3 in the chronic constriction injury 
model of neuropathic pain (Racz et al., 2005; Hösl et al., 2006). It 
is apparent, therefore, that unlike its clear role in certain types of 
inﬂ  ammatory pain, GlyR α3 is not critical for the induction or 
maintenance of neuropathic pain.
VISCERAL PAIN
Bowel disorders such as irritable bowel syndrome (IBS) are char-
acterised by poorly localised abdominal pain and sufferers dis-
play visceral hypersensitivity to experimental colorectal distension 
compared with healthy volunteers (Verne et al., 2001). To inves-
tigate the potential role of GlyR α3 in such bowel complaints we 
used a method of colorectal distension which produces a quan-
tiﬁ  able visceromotor response in lightly anaesthetised mice. In 
this study, although the magnitude of the VMR was dependent 
on the applied pressure, no signiﬁ  cant differences were observed 
between genotypes. This contrasts with other studies using the 
acetic acid writhing test, which reported a signiﬁ  cant attenuation 
in the writhing responses in Glra3−/− mice (Racz et al., 2005). This 
model, however, is often difﬁ  cult to interpret as little is known 
about the pathophysiology following acetic acid injection. The 
acute testing regimen utilised in this study, however, may not be 
sufﬁ  ciently long to involve the proposed EP2 receptor – GlyR α3 
signalling pathway. A phenotype using the CRD model might be 
uncovered by future experiments involving colonic hypersensitiv-
ity where VMR are recorded in response to an irritant injected 
intra-colonically which enhance the VMR to both noxious and 
non-noxious intensities in rats (Coutinho et al., 1996), although 
care must be taken to avoid general systemic effects (Deitch et al., 
1992).
CONCLUSION
Since the contribution of a particular molecular substrate to the 
nociceptive phenotype will most likely depend on the origin of 
the pain (e.g. inﬂ  ammatory, neuropathic or dysfunctional), the 
temporal characteristics (i.e. acute or chronic), and the underlying 
sensitivity (peripheral or central) it is likely that different substrates 
underlie different pain states.
A selective role of GlyR α3 can be observed based on clear effects 
in the CFA model, yet there is no clear role in other inﬂ  ammatory, 
neuropathic or visceral pain models. This study, therefore, suggests 
that GlyR α3 may play an important role in mediating PGE2-
induced sensitisation, but only in certain pain states. Previously, 
GlyR α3 has been found not to contribute to behavioural hypersen-
sitivity following formalin injection (Hösl et al., 2006). Although 
this model, like most models of peripheral injury, evokes spinal 
PGE2 release and is attenuated by COX inhibitors, it most likely 
reﬂ  ects a different downstream target since EP2 receptor knock-
out mice, but not Glra3−/− mice, displayed attenuated nocifensive 
behaviour. This could also hold true for the other inﬂ  ammatory 
models investigated in this study and may point to the differential 
involvement of other prostanoids and EP receptors, located either Frontiers in Molecular Neuroscience  www.frontiersin.org  November 2009  | Volume 2  |  Article 14  |  7
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centrally or peripherally, that may activate different molecular 
effectors (e.g. Matsumoto et al., 2005; Hutchinson et al., 2009). 
What is clear, however, is that different inﬂ  ammatory pain states 
are underpinned by different molecular substrates such that their 
investigation will help to dissect out pain-state speciﬁ  c mecha-
nisms. These observations may be reﬂ  ected in different clinical 
phenotypes and, as such, a more mechanistic based approach may 
be required in the clinic.
ACKNOWLEDGMENTS
Robert J. Harvey and Anthony H. Dickenson conceived the study, 
Victoria L. Harvey and Anthony H. Dickenson designed and per-
formed the experiments, analysed data and wrote the manuscript 
with input from all authors. Alex Caley provided mouse genotyp-
ing; Robert J. Harvey and Ulrike C. Müller generated and supplied 
the Glra3−/− mice. This work was supported by MRC Project Grant 
(G0500833) to Robert J. Harvey and Anthony H. Dickenson.
REFERENCES
Ahmadi, S., Lippross, S., Neuhuber, W. L., 
and Zeilhofer, H. U. (2002). PGE2 
selectively blocks inhibitory glycin-
ergic neurotransmission onto rat 
superﬁ  cial dorsal horn neurons. Nat. 
Neurosci. 5, 34–40.
Bove, S. E., Calcaterra, S. L., Brooker, R. M., 
Huber, C. M., Guzman, R. E., 
Juneau,  P.  L., Schrier, D. J., and 
Kilgore, K. S. (2003). Weight bearing as 
a measure of disease progression and 
efﬁ  cacy of anti-inﬂ  ammatory com-
pounds in a model of monosodium 
iodoacetate-induced osteoarthritis. 
Osteoarthr. Cartil. 11, 821–830.
Chaplan, S. R., Bach, F. W., Pogrel, J. W., 
Chung, J. M., and Yaksh, T. L. (1994). 
Quantitative assessment of tactile 
allodynia in the rat paw. J. Neurosci. 
Methods 53, 55–63.
Coutinho, S. V., Meller, S. T., and 
Gebhart, G. F. (1996). Intracolonic 
zymosan produces visceral hyperalge-
sia in the rat that is mediated by spinal 
NMDA and non-NMDA receptors. 
Brain Res. 736, 7–15.
Deitch, E. A., Specian, R. D., Grisham, M. B., 
and Berg, R. D. (1992). Zymosan-
induced bacterial translocation: a 
study of mechanisms. Crit. Care Med. 
20, 782–788.
Dirig, D. M., Isakson, P. C., and Yaksh, T. L. 
(1998). Effect of COX-1 and COX-2 
inhibition on induction and mainte-
nance of carrageenan-evoked thermal 
hyperalgesia in rats. J. Pharmacol. Exp. 
Ther. 285, 1031–1038.
Dirig, D. M., and Yaksh, T. L. (1999). 
In vitro prostanoid release from spi-
nal cord following peripheral inﬂ  am-
mation: effects of substance P, NMDA 
and capsaicin. Br. J. Pharmacol. 126, 
1333–1340.
Guay, J., Bateman, K., Gordon, R., 
Mancini, J., and Riendeau, D. (2004). 
Carrageenan-induced paw edema 
in rat elicits a predominant pros-
taglandin E2 (PGE2) response in the 
central nervous system associated 
with the induction of microsomal 
PGE2 synthase-1. J. Biol. Chem. 279, 
24866–24872.
Harvey, R. J., Depner, U. B., Wässle, H., 
Ahmadi, S., Heindl, C., Reinold, H., 
Smart, T. G., Harvey, K., Schutz, B., 
Abo-Salem, O. M., Zimmer, A., 
Poisbeau, P., Welzl, H., Wolfer, D. P., 
Betz, H., Zeilhofer, H. U., and 
Müller, U. (2004). GlyR α3: an essen-
tial target for spinal PGE2-mediated 
inflammatory pain sensitization. 
Science 304, 884–887.
Harvey, V. L., and Dickenson, A. H. (2009). 
Behavioural and electrophysiological 
characterisation of experimentally 
induced osteoarthritis and neuropathy 
in C57Bl/6 mice. Mol. Pain 5, 18.
Hösl, K., Reinold, H., Harvey, R. J., 
Müller,  U., Narumiya, S., and 
Zeilhofer, H. U. (2006). Spinal prostag-
landin E receptors of the EP2 subtype 
and the glycine receptor α3 subunit, 
which mediate central inﬂ  ammatory 
hyperalgesia, do not contribute to pain 
after peripheral nerve injury or forma-
lin injection. Pain 126, 46–53.
Hutchinson, A. J., Chou, C. L., Israel, D. D., 
Xu, W., and Regan, J. W. (2009). 
Activation of EP2 prostanoid recep-
tors in human glial cell lines stimulates 
the secretion of BDNF. Neurochem. 
Int. 54, 439–446.
Kamp, E. H., Jones, R. C., 3rd, 
Tillman, S. R., and Gebhart, G. F. 
(2003). Quantitative assessment and 
characterization of visceral nocic-
eption and hyperalgesia in mice. Am. 
J. Physiol. Gastrointest. Liver Physiol. 
284, G434–G444.
Kolhekar, R., Murphy, S., and Gebhart, G. F. 
(1997). Thalamic NMDA receptors 
modulate inflammation-produced 
hyperalgesia in the rat. Pain 71, 31–40.
Ma, W., Du, W., and Eisenach, J. C. (2002). 
Role for both spinal cord COX-1 and 
COX-2 in maintenance of mechanical 
hypersensitivity following peripheral 
nerve injury. Brain Res. 937, 94–99.
Malmberg, A. B., and Basbaum, A. I. 
(1998). Partial sciatic nerve injury in 
the mouse as a model of neuropathic 
pain: behavioral and neuroanatomical 
correlates. Pain 76, 215–222.
Malmberg, A. B., and Yaksh, T. L. (1994). 
Capsaicin-evoked prostaglandin E2 
release in spinal cord slices: relative 
effect of cyclooxygenase inhibitors. 
Eur. J. Pharmacol. 271:293–299.
Matsumoto, S., Ikeda, M., Yoshida, S., 
Tanimoto, T., Takeda, M., and Nasu, M. 
(2005). Prostaglandin E2-induced 
modiﬁ  cation of tetrodotoxin- resistant 
Na+ currents involves activation of 
both EP2 and EP4 receptors in neo-
natal rat nodose ganglion neurones. 
Br. J. Pharmacol. 145, 503–513.
Neugebauer, V., Han, J. S., Adwanikar, H., 
Fu, Y., and Ji, G. (2007). Techniques for 
assessing knee joint pain in arthritis. 
Mol. Pain 3, 8.
Pomonis, J. D., Boulet, J. M., Gottshall, S. L., 
Phillips, S., Sellers, R., Bunton, T., and 
Walker, K. (2005). Development and 
pharmacological characterization of a 
rat model of osteoarthritis pain. Pain 
114, 339–346.
Racz, I., Schutz, B., Abo-Salem, O. M., 
and Zimmer, A. (2005). Visceral, 
inﬂ  ammatory and neuropathic pain 
in glycine receptor α3-deﬁ  cient mice. 
Neuroreport 16, 2025–2028.
Reinold, H., Ahmadi, S., Depner, U. B., 
Layh, B., Heindl, C., Hamza, M., Pahl, A., 
Brune, K., Narumiya, S., Müller, U., and 
Zeilhofer, H. U. (2005). Spinal inﬂ  am-
matory hyperalgesia is mediated by 
prostaglandin E receptors of the EP2 
subtype. J. Clin. Invest. 115, 673–679.
Schafers, M., Marziniak, M., Sorkin, L. S., 
Yaksh, T. L., and Sommer, C. (2004). 
Cyclooxygenase inhibition  in 
  nerve-injury- and TNF-induced 
hyperalgesia in the rat. Exp. Neurol. 
185, 160–168.
Verne, G. N., Robinson, M. E., and 
Price, D. D. (2001). Hypersensitivity 
to visceral and cutaneous pain in the 
irritable bowel syndrome. Pain 93, 
7–14.
Vonsy, J. L., Ghandehari, J., and 
Dickenson, A. H. (2008). Differential 
analgesic effects of morphine and 
gabapentin on behavioural measures 
of pain and disability in a model of 
osteoarthritis pain in rats. Eur. J. Pain 
13, 786–793.
Yang, L. C., Marsala, M., and Yaksh, T. L. 
(1996). Characterization of time 
course of spinal amino acids, citrulline 
and PGE2 release after carrageenan/
kaolin-induced knee joint inﬂ  amma-
tion: a chronic microdialysis study. 
Pain 67, 345–354.
Conflict of Interest Statement: The 
authors declare that the research was con-
ducted in the absence of any commercial 
or ﬁ  nancial relationship that could be con-
strued as a potential conﬂ  ict of interest.
Received: 31 July 2009; paper pending pub-
lished: 16 August 2009; accepted: 27 August 
2009; published online: 04 November 2009.
Citation: Harvey VL, Caley A, Müller 
UC, Harvey RJ and Dickenson AH 
(2009) A  selective role for α3 subu-
nit glycine receptors in inflammatory 
pain. Front. Mol. Neurosci. 2:14. doi: 
10.3389/neuro.02.014.2009
Copyright © 2009 Harvey, Caley, Müller, 
Harvey and Dickenson. This is an open-access 
article subject to an exclusive license agree-
ment between the authors and the Frontiers 
Research Foundation, which permits unre-
stricted use, distribution, and reproduction in 
any medium, provided the original authors 
and source are credited.